Full Press Release Details
SAN DIEGO, Oct. 13, 2015 (GLOBE NEWSWIRE) -- Tandem Diabetes Care®, Inc. (NASDAQ:TNDM), a medical device company and manufacturer of the t:slim®, t:flex®and t:slim G4™Insulin Pumps, plans to release its third quarter 2015 results after the financial markets close on Thursday, October 29, 2015. The Company will hold a conference call and simultaneous webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific Time), to discuss its third quarter 2015 financial and operating results.
Conference Call/Webcast Details:Date:October 29, 2015Time:4:30pm Eastern Time (1:30pm Pacific Time)Toll Free Dial-In Number:(855) 427-4396International Dial-In Number:(484) 756-4261Conference ID: 54342520Webcast Link:http://edge.media-server.com/m/p/f3gpecju
An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located athttp://investor.tandemdiabetes.comin the “Investor Events” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4™ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity. Tandem is based in San Diego, California.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim, #tflex, #tslimG4, #tconnect and $TNDM.Follow Tandem Diabetes Care on Facebook atwww.facebook.com/TandemDiabetes.
t:slim, t:flex, and Tandem Diabetes Care are registered trademarks, and t:slim G4 is a trademark of Tandem Diabetes Care, Inc.